AKAN Stock Overview
Akanda Corp., through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis products to patients worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Akanda Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.10 |
| 52 Week High | US$2.70 |
| 52 Week Low | US$0.086 |
| Beta | 1.61 |
| 1 Month Change | -37.54% |
| 3 Month Change | -74.87% |
| 1 Year Change | -89.90% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -99.90% |
Recent News & Updates
Shareholder Returns
| AKAN | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | 9.1% | 0.7% | 2.9% |
| 1Y | -89.9% | 10.8% | 22.2% |
Return vs Industry: AKAN underperformed the US Pharmaceuticals industry which returned 10.6% over the past year.
Return vs Market: AKAN underperformed the US Market which returned 21.9% over the past year.
Price Volatility
| AKAN volatility | |
|---|---|
| AKAN Average Weekly Movement | 24.6% |
| Pharmaceuticals Industry Average Movement | 9.7% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: AKAN's share price has been volatile over the past 3 months.
Volatility Over Time: AKAN's weekly volatility has increased from 18% to 25% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2021 | 46 | Katie Field | www.akandacorp.com |
Akanda Corp., through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis products to patients worldwide. It offers medicinal-grade cannabis and cannabis based medical and wellness products. The company was incorporated in 2021 and is headquartered in New Romney, the United Kingdom.
Akanda Corp. Fundamentals Summary
| AKAN fundamental statistics | |
|---|---|
| Market cap | US$872.39k |
| Earnings (TTM) | -US$15.27m |
| Revenue (TTM) | US$3.94m |
0.2x
P/S Ratio-0.1x
P/E RatioIs AKAN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AKAN income statement (TTM) | |
|---|---|
| Revenue | US$3.94m |
| Cost of Revenue | -US$167.63k |
| Gross Profit | US$4.11m |
| Other Expenses | US$19.38m |
| Earnings | -US$15.27m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.80 |
| Gross Margin | 104.25% |
| Net Profit Margin | -387.08% |
| Debt/Equity Ratio | 22.8% |
How did AKAN perform over the long term?
See historical performance and comparison